Literature DB >> 2972746

Bilateral optic neuropathy associated with amiodarone therapy.

S M Nazarian1, W M Jay.   

Abstract

Amiodarone, an antiarrhythmic agent, has been associated with mild visual loss secondary to papillopathy and papilledema. We report a patient who developed bilateral optic neuropathy 4 weeks after initiation of amiodarone therapy. Nine months later, his vision was 20/50 in the right eye and 20/200 in the left. This report provides additional evidence that amiodarone may cause toxic optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972746

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  8 in total

Review 1.  Amiodarone-associated optic neuropathy: a critical review.

Authors:  Rod S Passman; Charles L Bennett; Joseph M Purpura; Rashmi Kapur; Lenworth N Johnson; Dennis W Raisch; Dennis P West; Beatrice J Edwards; Steven M Belknap; Dustin B Liebling; Mathew J Fisher; Athena T Samaras; Lisa-Gaye A Jones; Katrina-Marie E Tulas; June M McKoy
Journal:  Am J Med       Date:  2012-03-03       Impact factor: 4.965

2.  Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?

Authors:  Katrin Fasler; Ghislaine L Traber; Gregor Peter Jaggi; Klara Landau
Journal:  Neuroophthalmology       Date:  2017-08-18

Review 3.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

4.  Amiodarone induced optic neuropathy.

Authors:  P K Nagra; R Foroozan; P J Savino; I Castillo; R C Sergott
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

5.  [Severe course and contingent risk factors in optic neuropathy and myelopathy after tuberculostatics].

Authors:  I B Frisch; A K Kunze; A Castro; H Krastel; H-M Meinck
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

6.  Absence of bilateral vision loss from amiodarone: a randomized trial.

Authors:  Joel S Mindel; Jill Anderson; Anne Hellkamp; George Johnson; Jeanne E Poole; Daniel B Mark; Kerry L Lee; Gust H Bardy
Journal:  Am Heart J       Date:  2007-05       Impact factor: 4.749

Review 7.  Clinically important ocular reactions to systemic drug therapy.

Authors:  I G Rennie
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

Review 8.  Clinical and Mechanistic Review of Amiodarone-Associated Optic Neuropathy.

Authors:  Reece Mitchell; Joseph Chacko
Journal:  Biomolecules       Date:  2022-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.